Archived articles


Toxic trade-offs
Published March 17, 2023
While advances in immunotherapy have dramatically improved cancer survival, unleashing the immune system can lead to a host of adverse reactions. How can patients pay less of a price?
Cancer research
Machine learning can help predict patient response to cancer immunotherapy
Published Nov 17, 2022
Algorithm gives insights into the biology behind an effective immune response
Cancer research
FDA approves new immunotherapy treatment regimen for melanoma patients
Published March 25, 2022
The treatment was developed and studied by researchers at Johns Hopkins and targets aggressive forms of skin cancer
Cancer Moonshot renewal could bring ambitious goals within reach
Published Feb 8, 2022
Johns Hopkins cancer researcher Elizabeth Jaffee, who co-led the Cancer Moonshot Blue Ribbon Panel in 2016, discusses how far cancer research has come in the past five years and where it's headed in the next few decades
Cancer research
Pioneering method examines how immunotherapy changes tumors
Published Oct 13, 2021
The non-invasive technique using an optical probe provides early signs of how a tumor is responding to treatment
Cancer research
Immunotherapy better than chemo at treating rare form of skin cancer
Published March 5, 2019
Drug marketed as Keytruda shown to be more effective than chemotherapy at treating Merkel cell carcinoma
Cancer research
Suppressing YAP protein gives immunotherapy a boost
Published Aug 7, 2018
In mouse study, researchers find that turning off YAP protein in regulatory T-cells enhances anti-tumor immune response
Cancer research
FDA approves cancer drug for personalized immunotherapy approach
Published May 25, 2017
Drug was developed from 30 years of basic research at Johns Hopkins
Cancer research
Immune to immunotherapy
Published Jan 6, 2017
Johns Hopkins scientists zero in on process that helps cancer cells evade immune system attacks during immunotherapy treatment
Cancer research
A landmark year for immunotherapy
Published Dec 28, 2016
Bloomberg–Kimmel Institute for Cancer Immunotherapy director recaps five major research findings from 2016